Cytecare Hospitals launches Institute for Dialysis and Renal Diseases

05 September 2023 | News

Aimed at providing comprehensive care and treatment for individuals with kidney failure or dysfunction

In India, nearly 2.2 lakh patients are diagnosed with End Stage Renal Disease (ESRD) every year, resulting in a demand for 3.4 crore dialysis annually, according to the Pradhan Mantri National Dialysis Programme. With approximately 4950 dialysis centres, largely in the private sector in India, the demand is less than half met with existing infrastructure. Not to forget, the high cost of the treatment, which makes it inaccessible to a majority of the population.

In its attempt to address this gap, Cytecare Hospitals, in collaboration with Humanist Centre for Medicine, a Bengaluru-based NGO, that aims to bridge funding gaps for patients seeking medical treatment, has launched a state-of-the-art Nephrology Institute to provide essential medical care and holistic treatment to individuals suffering from kidney failure or dysfunction.

The Institute’s primary purpose is to provide life-sustaining dialysis treatment, enhance patients' quality of life, and help manage the complications associated with kidney failure, including critical care support.

The team comprises highly skilled clinicians who will extend their expertise beyond outpatient consultations to provide comprehensive care for kidney-related ailments. Alongside clinical services, the Institute is equipped with state-of-the-art dialysis machines, reaffirming the hospital’s dedication to offering a wide spectrum of high-quality medical services under one roof.

"The Humanist-Cytecare Institute will offer a range of services aimed at providing comprehensive care and treatment for individuals with kidney failure or severe kidney dysfunction. These services are designed to address the medical needs of the patients as well as their overall well-being”, said Suresh Ramu, Co-founder and CEO, Cytecare Hospitals.




× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account